October 12, 2024 ADHD now affects 15.5 million US adults, says new CDC report Diagnoses of ADHD are on the rise among adults in the U.S. Approximately 15.5 million adults had a diagnosis in 2023, according to a new CDC report. A psychotherapist weighs in.
October 11, 2024 Breast cancer patient says new type of chemo saved her life: ‘I am thriving’ A medical clinic in Scottsdale, Arizona, offers an alternative, personalized form of chemotherapy designed to target cancer cells without harming healthy cells. A woman says it saved her life.
October 10, 2024 Hurricane Helene causes dire IV fluid shortage at hospitals nationwide An IV fluids plant that supplies a majority of America's health care system has been impacted by Hurricane Helene. Dr. Kenneth Perry discusses the importance of this treatment for various conditions.
October 9, 2024 British doctor admits to attempted murder after injecting mother’s partner with poison disguised as vaccine British doctor, Thomas Kwan, pleaded guilty to an attempted murder charge after 'overwhelming' evidence showed he administer a poisonous fake COVID vaccination.
October 7, 2024 Aging slowdown could be surprise benefit of existing medication, research shows A drug used to prevent organ rejection in kidney transplant patients is being touted for potentially slowing down aging. Experts comment on the potential benefits and the need for more research.
October 6, 2024 Hurricane Helene flooding in NC stirs yellow jacket swarms, prompting distribution of Benadryl and EpiPens Swarms of stinging insects in North Carolina are swarming those trying to recover from the aftermath of Hurricane Helene, prompting the distribution of Benadryl and epinephrine injections.
October 1, 2024 Does everyone need to take vitamins — and which are most important? Here’s what to know More than half of American adults took dietary supplements between 2017 and 2020 — but are vitamins really essential for everyone? Experts share what you need to know.
September 27, 2024 New schizophrenia drug gets FDA approval, taking novel approach to treating brain disorder On Thursday, the U.S. Food and Drug Administration approved COBENFY, an oral medication that marks the first new class of drugs for schizophrenia in more than 30 years.
September 24, 2024 Green tea for fueling weight loss? Experts reveal the skinny truth Recently, social media posts have been buzzing about green tea as a way to shed pounds without the medication and high costs. Experts discuss the beverage's weight-loss potential.
September 23, 2024 Nasal spray flu vaccine gets FDA approval for home use: ‘A good alternative’ The U.S. Food and Drug Administration has approved FluMist — the nasal spray flu vaccine — for home use by a patient or adult caregiver. Dr. Nicole Saphier and Dr. Marc Siegel weigh in.